Digg It - Business

What is Venture Capital?

Funding a company through venture capital refers to investment made by outside people for the businesses that are eithe

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

r struggling or new and growing. Funding a company through venture capital involves potentially a high degree of risk. However, the potential ret

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

urns are also far better than the average returns on other types of investments. The people who dare to make such investments are known as ventur

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

e capitalists. A pool of investments that shows more interest in investing the money of third-party investors in the businesses that are consider

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ed more risky according to the market parameters is known as a venture capital fund.

The entrepreneurs who are in need of venture capital for th

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ir struggling or new businesses always look for this kind of facility. The person who is ideal for these start-up enterprises is a mentoring capi

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

talist. A mentor capitalist is capable of not only arranging the funds for these businesses but also guiding them to solve their problems.

Treme

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ndous Growth In The Last 25 Years

In the last two and a half decades, there has been an extraordinary growth in the field of funding a company t

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

hrough venture capital. Until 1980; the total value of the assets managed by the venture capitalists was approximately $3 billion. Ten years late

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

r, that figure was raised by venture capitalists in only one year. By the year 2000, the venture capitalists started raising that money every qua

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ter. There was a slowdown when the dot-com bubble burst, yet the level of funding a company through venture capital is still much higher than in

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

the past. However, even after this much growth, there is a shortage of venture capital funds because the people seeking these funds are increasin

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

g at a faster rate.

How To Categorize?

Funding a company through venture capital can be categorized according to the type of the industry on wh

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ich the venture capitalists are focusing. Most of the firms are interested in investing in a particular kind of industry. Only a few firms can in

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

vest in any type of business. Some firms invest only in the companies that are located in a particular geographical area; others invest only in c

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

mpanies that use a particular technology.

The life cycle of the company that is receiving the funds is also a criterion on the basis of which ve

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

nture capital funding can be categorized. The number of venture capitalists interested in funding a new startup is very small. Most of the ventur

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

e capitalists prefer to invest in companies that have survived initial growth problems.

Do Proper Homework For Getting Venture Capital

If you a

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

re interested in seeking support from the venture capital funding, then do your homework carefully. Gather information about the different ventur

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

e capitalists and ask only those people who are interested in funding such types of proposal. There is no point in mailing blindly to just anyone

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/19746/diggit-Funding-A-Company-Through-Venture-Capital.html">Funding A Company Through Venture Capital</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/19746/diggit-Funding-A-Company-Through-Venture-Capital.html]Funding A Company Through Venture Capital[/url]

When accepting a new job, salary negotiation is so important. You may have to consider many additional costs that may not be readily apparent to you, which the new job may demand and which are not there in your present job. The costs may or may not be quantifiable but it is important to be aware of them when thinking of salary negotiation. This article explains these issues in more detail.

The successful modern recruiter must now eschew resumes for a vast web of relationships. A successful recruiter must develop an active and dynamic circle of talented people who have skills and abilities that can be matched to the ever-changing needs of hiring managers.

Following these essential boundaries will help entrepreneurial couples ease the transition to working together.

Tags

Links

Digg It - Funding A Company Through Venture Capital

Related Articles: